AIML Announces Proposed Private Placement

Rhea-AI Summary

AI/ML Innovations (OTCQB:AIMLF) has announced plans for a non-brokered private placement offering of up to 31,000,000 units at $0.05 per unit, aiming to raise gross proceeds of up to $1.55 million.

Each unit consists of one common share and one warrant, with each warrant exercisable at $0.15 per share for a five-year term. The securities will have a four-month and one-day hold period. The company plans to use the proceeds for working capital requirements and will pay finder's fees to qualified finders. The private placement remains subject to necessary approvals, including from the Canadian Securities Exchange.

Positive

• Potential to raise up to $1.55 million in fresh capital
• Long-term warrant term of 5 years provides extended funding flexibility
• Warrants priced at $0.15, representing 200% premium to unit price

Negative

• Significant dilution with up to 31 million new units being issued
• Offering price of $0.05 per unit may indicate current market weakness
• Additional dilution possible through finder's fee payments in securities

VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 31,000,000 units ("Units") at a price of $0.05 per Unit for gross proceeds of up to $1,550,000 ("Private Placement").

Each Unit is comprised of one Common Share and one warrant which will be exercisable into one (1) Common Share of the Company (each a "Warrant"). Each Warrant will have a term of five (5) years and will entitle the holder to purchase one (1) Common Share at a price of $0.15 per Common Share following the closing date. The Common Shares and Warrants comprising the Units will be subject to a four-month and one day hold period in accordance with the policies of the Canadian Securities Exchange ("CSE") and applicable securities legislation.

The Company intends to use net proceeds of the Private Placement for working capital requirements.

The Company will pay a finder's fee to qualified finders who assist in selling the Units, in cash or securities or a combination of both, as permitted by CSE policy and applicable securities laws.

The Private Placement is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval from the CSE.

For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.

Contact:
Blake Fallis at
(778) 405-0882
info@aiml.health

About AI/ML Innovations Inc.
https://www.aiml.health/

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

On behalf of the Board of Directors:
Paul Duffy, Executive Chairman

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including with respect to the completion of the Private Placement. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of AIML, including the timing and nature of all deliverables associated with the Private Placement and whether the Private Placement will be completed as currently proposed or at all. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

SOURCE: AI/ML Innovations, Inc.

View the original press release on ACCESS Newswire

FAQ

What is the size and price of AIMLF's proposed private placement?

AI/ML Innovations is offering up to 31 million units at $0.05 per unit, aiming to raise up to $1.55 million in gross proceeds.

What are the terms of the warrants in AIMLF's private placement?

Each warrant has a 5-year term and allows holders to purchase one common share at $0.15 per share following the closing date.

How will AIMLF use the proceeds from the private placement?

The company intends to use the net proceeds for working capital requirements.

What is the hold period for AIMLF's private placement securities?

The Common Shares and Warrants will have a four-month and one day hold period in accordance with CSE policies and securities legislation.

What approvals does AIMLF need for the private placement?

The private placement requires approval from the Canadian Securities Exchange (CSE) and other necessary regulatory approvals.